BNP Paribas Financial Markets decreased its position in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 4.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,562,197 shares of the company’s stock after selling 118,686 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.19% of Keurig Dr Pepper worth $96,031,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ashton Thomas Securities LLC purchased a new stake in Keurig Dr Pepper in the 3rd quarter valued at about $25,000. Blue Trust Inc. raised its position in Keurig Dr Pepper by 312.1% in the second quarter. Blue Trust Inc. now owns 849 shares of the company’s stock valued at $26,000 after purchasing an additional 643 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its stake in Keurig Dr Pepper by 617.1% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 796 shares of the company’s stock worth $27,000 after purchasing an additional 685 shares in the last quarter. Farmers & Merchants Investments Inc. boosted its position in shares of Keurig Dr Pepper by 51.5% during the second quarter. Farmers & Merchants Investments Inc. now owns 886 shares of the company’s stock worth $30,000 after buying an additional 301 shares during the period. Finally, Hantz Financial Services Inc. acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at $35,000. 85.23% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $32.65, for a total transaction of $2,252,850,000.00. Following the transaction, the insider now owns 214,443,879 shares of the company’s stock, valued at $7,001,592,649.35. This trade represents a 24.34 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 1.00% of the company’s stock.
Keurig Dr Pepper Trading Down 0.6 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last posted its earnings results on Thursday, October 24th. The company reported $0.51 earnings per share for the quarter, meeting the consensus estimate of $0.51. The business had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The business’s quarterly revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.48 EPS. On average, sell-side analysts expect that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.
Keurig Dr Pepper Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were given a dividend of $0.23 per share. The ex-dividend date of this dividend was Friday, September 27th. This is a positive change from Keurig Dr Pepper’s previous quarterly dividend of $0.22. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.82%. Keurig Dr Pepper’s dividend payout ratio (DPR) is 55.76%.
Analyst Ratings Changes
Several research firms have weighed in on KDP. Evercore ISI raised Keurig Dr Pepper to a “hold” rating in a research report on Thursday, September 5th. Citigroup reduced their price objective on Keurig Dr Pepper from $43.00 to $40.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. TD Cowen boosted their target price on Keurig Dr Pepper from $35.00 to $40.00 and gave the stock a “hold” rating in a research note on Thursday, September 26th. JPMorgan Chase & Co. reduced their price target on Keurig Dr Pepper from $41.00 to $40.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Finally, Barclays lowered their price objective on Keurig Dr Pepper from $41.00 to $39.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $38.36.
Get Our Latest Stock Analysis on KDP
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More
- Five stocks we like better than Keurig Dr Pepper
- How Technical Indicators Can Help You Find Oversold Stocks
- Semler Stock Surges Over 130% in November: A New Bitcoin Play?
- How to invest in marijuana stocks in 7 steps
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Using the MarketBeat Dividend Tax Calculator
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.